In thisfree report, the Medical, Consulting, Policy, Access, Value, and Evidence experts of Fishawack Health interview patients, researchers, and biopharmaceutical leaders to explore the complex landscape in the development of cell and gene therapies, and share commercial recommendations from our specialist teams.
Follow the link to learn about:
An interview with Professor Francesco Dazzi, Medical Lead Cell Therapy, BioPharmaceuticals R&D at AstraZeneca, on the company’s novel cell therapy pipeline for chronic diseases
Patient and market access insights on leveraging CRISPR technology for hematologic diseases
The evolving policy and regulatory landscape for cell and gene therapies
Trends shaping the future of personalized medicine
Steps for communicating the complex science to a variety of stakeholders
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.